News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,789 Results
Type
Article (4171)
Company Profile (12)
Press Release (93606)
Section
Business (42424)
Career Advice (475)
Deals (6832)
Drug Delivery (11)
Drug Development (8887)
Employer Resources (21)
FDA (1366)
Job Trends (1794)
News (57597)
Policy (3607)
Tag
2027 Biotech Bay Standard (1)
Academia (377)
Academic (1)
Accelerated approval (6)
Adcomms (3)
Allergies (11)
Alliances (5454)
ALS (18)
Alzheimer's disease (198)
Antibody-drug conjugate (ADC) (16)
Approvals (1373)
Artificial intelligence (50)
Autoimmune disease (20)
Automation (2)
Bankruptcy (28)
Best Places to Work (1546)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (10)
Bladder cancer (14)
Brain cancer (9)
Breast cancer (33)
Cancer (501)
Cardiovascular disease (32)
Career advice (403)
Career pathing (4)
CAR-T (28)
CDC (3)
Cell therapy (78)
Cervical cancer (5)
Clinical research (7714)
Collaboration (121)
Compensation (86)
Complete response letters (3)
COVID-19 (324)
CRISPR (14)
C-suite (53)
Cystic fibrosis (14)
Data (714)
Denatured (1)
Depression (8)
Diabetes (58)
Diagnostics (876)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (26)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (19)
Earnings (35078)
Editorial (8)
Employer branding (1)
Employer resources (18)
Events (7057)
Executive appointments (65)
FDA (1888)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (144)
Gene editing (29)
Generative AI (8)
Gene therapy (74)
GLP-1 (104)
Government (474)
Guidances (305)
Healthcare (2489)
HIV (13)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (19)
Immuno-oncology (6)
Indications (6)
Infectious disease (344)
Inflammatory bowel disease (21)
Inflation Reduction Act (1)
Influenza (9)
Intellectual property (32)
Interviews (94)
IPO (4389)
IRA (7)
Job creations (315)
Job search strategy (336)
JPM (6)
Labor market (5)
Layoffs (36)
Leadership (6)
Legal (757)
Liver cancer (6)
Longevity (1)
Lung cancer (65)
Lymphoma (54)
Machine learning (5)
Management (8)
Manufacturing (60)
MASH (31)
Medical device (2129)
Medtech (2138)
Mergers & acquisitions (2680)
Metabolic disorders (149)
Multiple sclerosis (21)
NASH (5)
Neurodegenerative disease (29)
Neuropsychiatric disorders (11)
Neuroscience (341)
NextGen: Class of 2026 (792)
Non-profit (534)
Now hiring (1)
Obesity (61)
Opinion (44)
Ovarian cancer (10)
Pain (19)
Pancreatic cancer (42)
Parkinson's disease (21)
Partnered (4)
Patents (54)
Patient recruitment (36)
Peanut (5)
People (4494)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (1898)
Phase 2 (3144)
Phase 3 (3270)
Pipeline (1801)
Policy (25)
Postmarket research (222)
Preclinical (923)
Press Release (8)
Prostate cancer (24)
Psychedelics (4)
Radiopharmaceuticals (30)
Rare diseases (88)
Real estate (421)
Recruiting (8)
Regulatory (2778)
Reports (9)
Research institute (473)
Resumes & cover letters (75)
Rett syndrome (12)
RNA editing (1)
RSV (4)
Schizophrenia (34)
Series A (15)
Series B (10)
Service/supplier (2)
Sickle cell disease (12)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (1)
Startups (343)
State (1)
Stomach cancer (1)
Supply chain (4)
Tariffs (6)
The Weekly (2)
Vaccines (81)
Venture capital (4)
Weight loss (32)
Women's health (9)
Worklife (2)
Date
Last 7 days (74)
Last 30 days (235)
Last 365 days (5020)
2026 (296)
2025 (5048)
2024 (5732)
2023 (6942)
2022 (9953)
2021 (9668)
2020 (8431)
2019 (6110)
2018 (4750)
2017 (4494)
2016 (3771)
2015 (5006)
2014 (3519)
2013 (2520)
2012 (2726)
2011 (3158)
2010 (2739)
Location
Africa (123)
Alabama (10)
Alaska (2)
Arizona (27)
Asia (4960)
Australia (772)
California (1847)
Canada (528)
China (105)
Colorado (83)
Connecticut (104)
Delaware (42)
Europe (12358)
Florida (257)
Georgia (51)
Idaho (11)
Illinois (107)
India (7)
Indiana (105)
Japan (30)
Kansas (9)
Kentucky (4)
Louisiana (7)
Maine (33)
Maryland (207)
Massachusetts (1365)
Michigan (120)
Minnesota (105)
Missouri (13)
Montana (4)
Nebraska (2)
Nevada (13)
New Hampshire (11)
New Jersey (578)
New Mexico (2)
New York (444)
North Carolina (237)
Northern California (912)
Ohio (33)
Oregon (3)
Pennsylvania (415)
Rhode Island (6)
South America (163)
South Carolina (7)
Southern California (774)
Tennessee (18)
Texas (334)
United States (6705)
Utah (80)
Virginia (28)
Washington D.C. (22)
Washington State (163)
Wisconsin (9)
97,789 Results for "basi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer
August 25, 2025
·
3 min read
Press Releases
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
July 31, 2025
·
10 min read
Press Releases
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
September 25, 2025
·
13 min read
Manufacturing
AbbVie Commits $100B in US R&D, Manufacturing, Winning Tariff, Pricing Exemptions
AbbVie has also pledged to participate in TrumpRx and offer many of its products, including Humira, on a direct-to-patient basis. In exchange, the pharma secured exemptions from tariffs and other future pricing directives.
January 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025
July 28, 2025
·
5 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Lead First Study to Identify Molecular Basis of Food Allergy
February 5, 2025
·
4 min read
Press Releases
Interactive Strength Inc. (Nasdaq:TRNR) Reiterates $75M Guidance, Expected Profitability in Q4 on Adjusted EBITDA Basis Due to Pending Sportstech, Wattbike Deals
May 21, 2025
·
4 min read
Regulatory
FDA To Publish Drug-Related Adverse Event Reports Daily
The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a quarterly basis.
August 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations
• Gross Profit increased 73% YoY • Gross Margin increased 500 basis points to 68% • Adjusted EBITDA loss reported at $1.46M vs $1.17M in year-ago quarter • Near-term business objectives are focused on preserving cash, stabilizing operations, and securing the financial resources required to support continuity of operations
November 26, 2025
·
16 min read
Press Releases
Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter
November 12, 2024
·
19 min read
1 of 9,779
Next